4.5 Article

Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [123I]FP-CIT SPECT

Journal

JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 404, Issue -, Pages 124-127

Publisher

ELSEVIER
DOI: 10.1016/j.jns.2019.07.025

Keywords

Parkinson's disease; Parkinsonism; Non-motor; Dopamine transporter; SPECT

Funding

  1. Finnish Parkinson Foundation
  2. Finnish Medical Foundation
  3. Paivikki and Sakari Sohlberg Foundation
  4. Academy of Finland [295724, 310835, 295580]
  5. Turku University Foundation
  6. Turku University Hospital (ERVA-funds)
  7. Finnish Cultural Foundation
  8. Orion Research Foundation
  9. Abbvie
  10. Orion
  11. Orion Pharma
  12. Nordic Infucare
  13. Academy of Finland (AKA) [310835, 310835, 295580, 295724, 295724, 295580] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Background: Non-motor symptoms (NMSs) are clearly more prevalent in Parkinson's disease (PD) patients compared to healthy individuals. However, NMSs are also common in the elderly and other neurological conditions, and thus, it is not known whether NMSs could be used to differentiate PD from parkinsonism/tremor without dopamine deficiency. Methods: We prospectively evaluated NMSs immediately before brain dopamine transporter (DAT) [I-123]FP-CIT SPECT scanning in 193 patients with unclear parkinsonism/tremor. According to the clinical follow-up and imaging results, 84 patients had PD. NMSs and their correlations with striatal DAT binding were investigated in PD patients and in parkinsonism/tremor patients with normal dopamine function. Results: Total NMS burden, anxiety or depression did not differ between PD patients and patients with normal DAT binding. DAT-normal patients reported more perception-related (p = 0.045) and attention/memory-related NMSs than PD patients (p < 0.001). Total NMS score did not correlate with striatal DAT binding in either group. Conclusions: In clinically uncertain cases, the total NMS burden cannot be used as a tool in distinguishing PD patients from patients with non-dopaminergic parkinsonism/tremor. Clinical screening of NMSs appears equally important in all patients with parkinsonism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available